DexCom Earnings Preview: What to Expect

Valued at a market cap of $25.5 billion, DexCom, Inc. (DXCM) is a medical device company that designs, develops, and commercializes continuous glucose monitoring (CGM) systems. The San Diego, California-based company’s products help patients, caregivers, and healthcare professionals manage diabetes and broader metabolic health conditions in real time. It is expected to announce its fiscal Q3 earnings for 2025 after the market closes on Thursday, Oct. 30. Before this event, analysts expect this medical dev ...